search text   Advanced Search

This Article Extract Full Text (PDF) P3Rs: Submit a response Alert me when this article is cited Alert me when P3Rs are posted Alert me if a correction is posted Citation Map Services E-mail this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My File Cabinet Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via ISI Web of Science (28) Citing Articles via Google Scholar Google Scholar Articles by Swedo, S. E. Articles by Rapoport, J. L. Search for Related Content PubMed PubMed Citation Articles by Swedo, S. E. Articles by Rapoport, J. L. Related Collections Neurology & Psychiatry Related AAP Red Book topics: Non-Group A or B Streptococcal and... Group A Streptococcal Infections

The Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infection (PANDAS) Subgroup: Separating Fact From Fiction

Pediatrics and Developmental Neuropsychiatry Branch
Intramural Research Program
National Institute of Mental Health
Bethesda, MD 20892
Division of Child Psychiatry
Brown University
Providence, RI 02912
Child Psychiatry Branch
Intramural Research Program
National Institute of Mental Health
Bethesda, MD 20892

Abbreviations: OCD, obsessive-compulsive disorder • PANDAS, pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection • NIMH, National Institute of Mental Health

Over a century ago, Sir William Osler wrote, "To carefully observe the phenomena of life in all its phases ... to call to aid the science of experimentation, to cultivate the reasoning faculty, so as to be able to know the true from the false—these are our methods."¹

These were also the methods that led to the discovery of poststreptococcal obsessive-compulsive disorder (OCD) and tic disorders and a decade of observations and research resulting in the description of a novel cohort of patients, the pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS) subgroup.^2,3 In this issue of Pediatrics, Kurlan and Kaplan raise questions about the veracity of these data.⁴ To respond, we will provide a brief literature review and clarification of the guidelines for management of a patient in the PANDAS subgroup.

The discovery of the PANDAS subgroup was the result of 2 parallel lines of clinical research conducted at the National Institute of Mental Health (NIMH): studies of children with OCD and investigations of children with Sydenham’s chorea, the neurologic manifestation of rheumatic fever. Systematic observations of children with OCD revealed that, although the majority of children had a gradual onset of symptoms over several weeks to months, a subgroup of the patients experienced an explosive "overnight" onset of obsessions and compulsions followed by a relapsing-remitting symptom course.⁵ Closer observation revealed that the neuropsychiatric symptom relapses frequently occurred after episodes of streptococcal pharyngitis or scarlet fever. These findings in OCD closely paralleled those from a series of investigations of Sydenham’s chorea.⁶ In those studies, 65% to 100% of children with Sydenham’s chorea were noted to have obsessive-compulsive symptoms, typically presenting 2 to 4 weeks before the onset of the adventitious movements and peaking in severity simultaneously with the chorea.^6,7 Longitudinal observations of the OCD subgroup and the patients with Sydenham’s chorea clearly demonstrated a temporal association between streptococcal infections and obsessive-compulsive symptoms. This relationship was not only observed consistently among patients presenting to the NIMH but also noted by several independent groups.^8–11 The nature of the association was unknown, and the observations could not elucidate whether the streptococcal infections played an etiologic role, but these issues would be addressed through subsequent scientific experimentation.

The title of the article by Kurlan and Kaplan⁴ provides a provocative starting point for discussion of the scientific hypotheses that derive from the clinical observations of the PANDAS subgroup. However, the authors subsequently blur the distinction between clinical observation and scientific investigation, leading them to dismiss the well-documented observations that neuropsychiatric symptoms are associated with streptococcal infections in the PANDAS subgroup because the etiology of PANDAS "remains a yet-unproven hypothesis."⁴ The authors thus recommend against obtaining throat cultures or serial titers in patients with abrupt-onset OCD and tics "until more definitive scientific proof is forthcoming." We strongly disagree with this recommendation. The continued threat of rheumatic fever mandates the detection and appropriate treatment of streptococcal infections, including asymptomatic infections, the leading cause of rheumatic carditis in the United States.¹² If one argues that OCD and tics are a manifestation of streptococcal infection for children in the PANDAS subgroup, then the infections aren’t really "silent" or "asymptomatic." In either case, a conservative treatment course would include administration of antibiotics for culture-proven streptococcal infections. In addition, Murphy and Pichichero¹¹ have documented that prompt treatment of streptococcal infections is associated with a rapid diminution of obsessive-compulsive symptom severity for some children in the PANDAS subgroup. Thus, the potential benefits of appropriate diagnosis and treatment of an occult streptococcal infection far outweigh the modest cost of obtaining a throat swab and culture. Of course, when throat cultures are obtained, there is a risk of falsely identifying a "carrier" as an asymptomatic infection, but this risk is small. Systematic studies typically report the frequency of carriers to be <5% to 10%.¹³ Thus, the vast majority of positive throat cultures represent true streptococcal infections, for which antibiotics administration is the accepted standard of care.

	CLINICAL CRITERIA

TOP CLINICAL CRITERIA SCIENTIFIC HYPOTHESES CLINICAL RECOMMENDATIONS CONCLUSIONS REFERENCES

 
Kurlan and Kaplan contend that the 5 criteria defining the PANDAS subgroup are not "particularly useful in distinguishing patients suspected of PANDAS from children with more typical cases of TS [Tourette’s syndrome] or OCD."⁴ In actuality, the criteria have been used successfully by a variety of clinical groups to define cohorts of patients with common clinical characteristics and a predictable clinical course.^3,9–11,14 This had been the original purpose of describing the PANDAS subgroup: to enable investigators to identify a clinically homogeneous group of patients for inclusion in research studies at the NIMH and elsewhere. Subsequent investigations have demonstrated that the criteria have clinical utility as well, in that they define a distinct cohort of patients who are uniquely responsive to novel therapeutic interventions and prevention strategies. The following is a clarification of the criteria.

The Presence of a Tic Disorder and/or OCD
The symptom characteristics and severity required for diagnosis are defined in the Diagnostic and Statistical Manual of Mental Disorders.¹⁵ The neuropsychiatric symptoms of the PANDAS subgroup were intentionally limited to tics and obsessive-compulsive symptoms because of our interest in establishing a homogeneous patient cohort for research studies. Subsequent interest in the PANDAS subgroup has sparked a number of authors to speculate that the criteria should be expanded to include other related disorders such as attention-deficit/hyperactivity disorder¹⁶ and anorexia.¹⁷ However, such a change requires systematic evidence documenting that the association between streptococcal infections and symptom onset in these disorders is not merely a chance finding; to date, such systematic studies have not been done.

Prepubertal Age at Onset, Usually Between 3 and 12 Years of Age
This criterion was based on historical data demonstrating that rheumatic fever and other poststreptococcal sequelae are uncommon before the age of 3 years and after the age of 12 years.¹⁸ Fischetti¹⁹ provides a possible explanation for the rarity of postpubertal sequelae of streptococcal infections and demonstrated the presence of serum antibodies conferring protection against streptococcal infections in 98% of healthy 12-year-old controls, making it unlikely that poststreptococcal neuropsychiatric symptoms would have their initial presentation after this age. Thus, we set the age range for the PANDAS subgroup at a point that had biological relevance and would include 98% of the cases.

Abrupt Symptom Onset and/or Episodic Course of Symptom Severity
Prospective longitudinal investigations have demonstrated that this criterion is the most useful in identifying children in the PANDAS subgroup.^2,3,9–11 Contrary to the concerns expressed by Kurlan and Kaplan,⁴ the abrupt onset of tics in the PANDAS subgroup is clearly different from the typical onset of an isolated, intermittent, simple motor or vocal tic, because children in the PANDAS subgroup experience the simultaneous onset of several different motor and vocal tics of such intensity and frequency that emergency treatment is often sought.¹⁴ PANDAS-related OCD is also easily distinguished from non-PANDAS OCD, because the latter patients have a slow, gradual symptom onset, whereas children in the PANDAS subgroup have an overnight "explosion" of obsessive-compulsive symptoms, reaching maximal, clinically significant impairment in 24 to 48 hours.^3,20

The episodic, relapsing-remitting course of the PANDAS subgroup is distinctly different from the undulating, waxing-waning course seen in other patients with OCD or tic disorders.^20,21 When the symptoms of a child in the PANDAS subgroup are graphed against time, a "saw-toothed" pattern emerges, in which periods of symptom quiescence are interrupted abruptly by severe symptom exacerbations; these relapses typically take several weeks to months to resolve. Prospective, longitudinal evaluation of these patients allows for documentation of the relationship between the symptom exacerbations and streptococcal infections: throat cultures obtained at the beginning of a symptom relapse will be positive, and titers obtained at baseline and 4 to 6 weeks later will demonstrate a clinically significant rise.

Temporal Association Between Symptom Exacerbations and Streptococcal Infections
Although it was postulated initially that there could be a significant time lag between the inciting streptococcal infection and the presentation of the neuropsychiatric sequelae (such as that seen in Sydenham’s chorea),⁶ clinical observations of the PANDAS subgroup revealed that the window is actually much narrower. Exacerbations of neuropsychiatric symptoms begin within 7 to 14 days after the streptococcal infection and usually occur simultaneously (ie, a throat culture obtained because of the recent onset of OCD and/or tics is positive).^3,11,20,21

One caveat in evaluating the relationship between streptococcal infections and neuropsychiatric symptoms is that the disorders are so common that co-occurrence can be a random coincidence rather than a clinically significant finding. OCD occurs in 1% to 2% of school-aged children, and transient motor tics occur in as many as 10% to 25% of early elementary students.^22,23 Furthermore, during regional streptococcal epidemics, the majority of children will be infected at least once during the outbreak.¹³ Thus, as discussed in our original report,³ a single positive throat culture or elevated antistreptococcal antibody titer is not sufficient to determine that a child’s neuropsychiatric symptoms are associated with streptococcal infections.^3,20 Instead, the determination that a child fits the PANDAS profile is made through prospective evaluation and documentation of the presence of streptococcal infections in conjunction with at least 2 episodes of neuropsychiatric symptoms, as well as demonstrating negative throat culture or stable titers during times of neuropsychiatric symptom remission.³ A child who has multiple symptom exacerbations without evidence of streptococcal infection would not be considered part of the PANDAS subgroup, nor would a child who has numerous streptococcal infections without subsequent symptom exacerbations.

Presence of Neurologic Abnormalities During Periods of Symptom Exacerbation
Neurologic examination of acutely ill children in the PANDAS subgroup reveals that 95% have choreiform movements.³ These fine piano-playing movements of the fingers are not easily confused with the writhing adventitious movements of Sydenham’s chorea.²⁴ Choreiform movements are not present at rest and must be elicited through stressed postures, whereas choreatic movements are present continuously and increase with unrelated voluntary movements. In addition, choreiform movements are an isolated finding, whereas the choreatic movements of Sydenham’s chorea are accompanied by a failure to sustain tetanic contractions (milk-maid’s grip, snake-like tongue) and muscle weakness.^6,18 Choreiform movements and chorea may share a common pathophysiology (related to dysfunction of the basal ganglia), but the clinical manifestations are quite distinct, and children in the PANDAS subgroup do not represent missed cases of Sydenham’s chorea. In fact, rheumatic fever, including Sydenham’s chorea, is a strict exclusionary criterion for the PANDAS subgroup.³

	SCIENTIFIC HYPOTHESES

TOP CLINICAL CRITERIA SCIENTIFIC HYPOTHESES CLINICAL RECOMMENDATIONS CONCLUSIONS REFERENCES

 
Clinical observations of the PANDAS subgroup led to a number of scientific hypotheses including the postulate that the tics and OCD represent sequelae of group A streptococcal infections. This etiologic hypothesis involves a series of factors including pathologic strains of group A streptococcal bacteria, host susceptibility (genetic, developmental, or other), and abnormal immune responsivity (Fig 1). The working model of pathogenesis not only provides a framework for understanding the etiology of OCD and tic disorders but also allows for the development of novel intervention and prevention strategies. A recent review provides a detailed description of the model as well as ongoing research efforts directed at understanding the pathologic mechanisms involved in the PANDAS subgroup.²⁵

View larger version (34K): [in this window] [in a new window]   Fig 1. Model of pathogenesis for PANDAS.

	CLINICAL RECOMMENDATIONS

TOP CLINICAL CRITERIA SCIENTIFIC HYPOTHESES CLINICAL RECOMMENDATIONS CONCLUSIONS REFERENCES

1. Laboratory testing: Children with an abrupt onset or exacerbation of OCD or tic disorder should have a throat culture obtained. If the symptoms have been present for >1 week, serial antistreptococcal titers may be indicated to document a preceding streptococcal infection. (Titers should be timed to catch the rise at 4–6 weeks.)
   
2. Use of antibiotics: Antibiotics are indicated only for the treatment of acute streptococcal infections as diagnosed by a positive throat culture or rapid streptococcal test. Clinical trials are underway to determine whether prophylactic antibiotics will be useful in the management of children in the PANDAS subgroup, but at present, they are not indicated. In the only placebo-controlled trial reported to date, penicillin administration failed to prevent streptococcal infections (14 of 35 infections occurred during the penicillin phase of the crossover trial), and thus there were no between-group differences in neuropsychiatric symptom severity.²⁷
   
3. Management of neuropsychiatric symptoms: Children in the PANDAS subgroup respond to treatment with standard pharmacologic and behavioral therapies. Obsessive-compulsive symptoms are treated best with a combination of medication (typically, a serotonin reuptake-blocking drug) and cognitive-behavior therapy, and motor and vocal tics respond to a variety of pharmacologic agents.
   
4. Immunomodulatory therapies: A randomized, placebo-controlled trial of intravenous immunoglobulin and therapeutic plasma exchange demonstrated significant and persistent improvements for a group of 29 severely affected children meeting criteria for the PANDAS subgroup.²⁸ The specificity of their response was demonstrated through a subsequent open-label trial of plasma exchange, which failed to produce benefits among children not meeting the PANDAS criteria.²⁹ After the publication of these reports, the American Society for Apheresis ranked therapeutic plasma exchange for poststreptococcal OCD and tic disorders "acceptable as second-line therapy or as an adjunct to primary therapy based on controlled trials."³⁰ Thus, immunomodulatory therapy may be a consideration for acutely and severely affected children in the PANDAS subgroup. Clinicians considering such an intervention are invited to contact the PANDAS research group at the NIMH for consultation.
   

	CONCLUSIONS

TOP CLINICAL CRITERIA SCIENTIFIC HYPOTHESES CLINICAL RECOMMENDATIONS CONCLUSIONS REFERENCES

 
The PANDAS subgroup is both a clinical entity and the subject of scientific experimentation. Systematic, longitudinal observations have demonstrated that the PANDAS subgroup has a distinct clinical presentation and an identifiable course of symptoms and that, for these children, there is a clear relationship between streptococcal infections and neuropsychiatric symptom exacerbations. Additional research is required to determine the nature of that relationship as well as to determine the etiopathogenesis of the poststreptococcal obsessive-compulsive symptoms and tics. Additional studies are required also to determine the role of immunomodulatory therapies and antibiotics prophylaxis for this group of patients. Meanwhile, it is time to end the debate about the existence of the PANDAS subgroup and begin to "call to aid the science of experimentation ... so as to be able to know the true from the false."

	FOOTNOTES

 
Received for publication Aug 27, 2003; Accepted Aug 27, 2003.

Address correspondence to Susan E. Swedo, MD, Pediatrics and Developmental Neuropsychiatry Branch, National Institute of Mental Health, 10 Center Dr, MSC 1255, Bethesda, MD 20892-1255. E-mail: swedos{at}mail.nih.gov

	REFERENCES

TOP CLINICAL CRITERIA SCIENTIFIC HYPOTHESES CLINICAL RECOMMENDATIONS CONCLUSIONS REFERENCES

 

1. Osler W. Aphorisms From His Bedside Teachings and Writings. Bean WB, ed. Springfield, IL: Charles C. Thomas, 1968
2. Allen AJ, Leonard HL, Swedo SE. Case study: a new infection-triggered, autoimmune subtype of pediatric OCD and Tourette’s syndrome. J Am Acad Child Adolesc Psychiatry.1995; 34 :307 –311[CrossRef][ISI][Medline]
3. Swedo SE, Leonard HL, Garvey MA, et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry.1998; 155 :264 –271[Abstract/Free Full Text]
4. Kurlan R, Kaplan EL. The pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS) etiology for tics and obsessive-compulsive symptoms: hypothesis or entity? Practical considerations for the clinician. Pediatrics.2004; 113 :883 –886[Abstract/Free Full Text]
5. Swedo SE, Rapoport JL, Leonard H, Lenane M, Cheslow D. Obsessive-compulsive disorder in children and adolescents: clinical phenomenology of 70 consecutive cases. Arch Gen Psychiatry.1989; 46 :335 –341[Abstract]
6. Swedo SE. Sydenham’s chorea: a model for childhood autoimmune neuropsychiatric disorders. JAMA.1994; 272 :1788 –1791[CrossRef][ISI][Medline]
7. Asbahr FR, Negrao AB, Gentil V, et al. Obsessive-compulsive and related symptoms in children and adolescents with rheumatic fever with and without chorea: a prospective 6-month study. Am J Psychiatry.1998; 155 :1122 –1124[Abstract/Free Full Text]
8. Murphy TK, Petitto JM, Voeller KK, Goodman WK. Obsessive compulsive disorder: is there an association with childhood streptococcal infections and altered immune function? Semin Clin Neuropsychiatry.2001; 6 :266 –276[Medline]
9. Tucker DM, Leckman JF, Scahill L, et al. A putative poststreptococcal case of OCD with chronic tic disorder, not otherwise specified. J Am Acad Child Adolesc Psychiatry.1996; 35 :1684 –1691[CrossRef][ISI][Medline]
10. Giulino L, Gammon P, Sullivan K, et al. Is parental report of upper respiratory infection at the onset of obsessive-compulsive disorder suggestive of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection? J Child Adolesc Psychopharmacol.2002; 12 :157 –164[CrossRef][ISI][Medline]
11. Murphy ML, Pichichero ME. Prospective identification and treatment of children with pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection (PANDAS). Arch Pediatr Adolesc Med.2002; 156 :356 –361[Abstract/Free Full Text]
12. Veasy LG, Tani LY, Hill HR. Persistence of acute rheumatic fever in the intermountain area of the United States. J Pediatr.1994; 124 :9 –16[CrossRef][ISI][Medline]
13. Shulman ST. Streptococcal pharyngitis: clinical and epidemiologic factors. Pediatr Infect Dis J.1989; 8 :816 –819[ISI][Medline]
14. Church AJ, Dale RC, Lees AJ, Giovannoni G, Robertson MM. Tourette’s syndrome: a cross-sectional study to examine the PANDAS hypothesis. J Neurol Neurosurg Psychiatry.2003; 74 :602 –607[Abstract/Free Full Text]
15. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fourth ed. Washington, DC: American Psychiatric Association; 1994
16. Peterson BS, Leckman JF, Tucker D, et al. Preliminary findings of antistreptococcal antibody titers and basal ganglia volumes in tic, obsessive-compulsive, and attention deficit/hyperactivity disorders. Arch Gen Psychiatry.2000; 57 :364 –372[Abstract/Free Full Text]
17. Sokol MS. Infection-triggered anorexia nervosa in children: clinical description of four cases. J Child Adolesc Psychopharmacol.2000; 10 :133 –145[ISI][Medline]
18. Stollerman GH. Rheumatic Fever and Streptococcal Infection. New York, NY: Grune & Stratton Inc; 1975
19. Fischetti V. The Streptococcus and the host. Present and future challenges. Adv Exp Med Biol.1997; 418 :15 –20[Medline]
20. Perlmutter SJ, Garvey MA, Castellanos X, et al. A case of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. Am J Psychiatry.1998; 155 :1592 –1598[Free Full Text]
21. Snider L, Swedo S. Pediatric obsessive-compulsive disorder. JAMA.2000; 284 :3104 –3106[Free Full Text]
22. Zohar AH. The epidemiology of obsessive-compulsive disorder in children and adolescents. Child Adolesc Psychiatr Clin N Am.1999; 8 :445 –460[ISI][Medline]
23. Snider LA, Seligman LD, Ketchen BR, et al. Tic and problem behaviors in school children: prevalence, characterization, and associations. Pediatrics.2002; 110 :331 –336[Abstract/Free Full Text]
24. Touwen BCL. Examination of the child with minor neurological dysfunction. In: Clinics in Developmental Medicine. Vol. 71. London, United Kingdom: Heinemann; 1979:53
25. Swedo SE. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS). Mol Psychiatry.2002; 7(suppl 2) :S24 –S25
26. Practice parameters for the assessment and treatment of children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry.1999; 38 :499 –500[Medline]
27. Garvey MA, Perlmutter SJ, Allen AJ, et al. A pilot study of penicillin prophylaxis for neuropsychiatric exacerbations triggered by streptococcal infections. Biol Psychiatry.1999; 45 :1564 –1571[CrossRef][ISI][Medline]
28. Perlmutter SJ, Leitman SF, Garvey MA, et al. Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood. Lancet.1999; 354 :1153 –1158[CrossRef][ISI][Medline]
29. Nicolson R, Swedo SE, Lenane M, et al. An open trial of plasma exchange in childhood-onset obsessive-compulsive disorder without post-streptococcal exacerbations. J Am Acad Child Adolesc Psychiatry.2000; 39 :1313 –1315[CrossRef][ISI][Medline]
30. Weinstein R. A period of trial in American apheresis medicine. Transfusion Apheresis Sci.2001; 25 :89 –91[CrossRef]

This article has been cited by other articles:

				V. Gabbay, B. J. Coffey, J. S. Babb, L. Meyer, C. Wachtel, S. Anam, and B. Rabinovitz Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcus: Comparison of Diagnosis and Treatment in the Community and at a Specialty Clinic Pediatrics, August 1, 2008; 122(2): 273 - 278. [Abstract] [Full Text] [PDF]

				D. Martino, A. Church, and G. Giovannoni Are antibasal ganglia antibodies important, and clinically useful? Practical Neurology, February 1, 2007; 7(1): 32 - 41. [Full Text] [PDF]

				P. Pavone, E. Parano, R. Rizzo, and R. R. Trifiletti Topical Review: Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infection: Sydenham Chorea, PANDAS, and PANDAS Variants J Child Neurol, September 1, 2006; 21(9): 727 - 736. [Abstract] [PDF]

				I Heyman, D Mataix-Cols, and N A Fineberg Obsessive-compulsive disorder. BMJ, August 26, 2006; 333(7565): 424 - 429. [Full Text] [PDF]

				K. Harris and H. S. Singer Tic Disorders: Neural Circuits, Neurochemistry, and Neuroimmunology J Child Neurol, August 1, 2006; 21(8): 678 - 689. [Abstract] [PDF]

				H. S. Singer, J. J. Hong, D. Y. Yoon, and P. N. Williams Serum autoantibodies do not differentiate PANDAS and Tourette syndrome from controls Neurology, December 13, 2005; 65(11): 1701 - 1707. [Abstract] [Full Text] [PDF]

				R. C. DALE, I. HEYMAN, G. GIOVANNONI, and A. W J. CHURCH Incidence of anti-brain antibodies in children with obsessive-compulsive disorder The British Journal of Psychiatry, October 1, 2005; 187(4): 314 - 319. [Abstract] [Full Text] [PDF]

				U. Chowdhury and I. Heyman Tourette's syndrome in children BMJ, December 11, 2004; 329(7479): 1356 - 1357. [Full Text] [PDF]

				Journal Watch Arch. Dis. Child., October 1, 2004; 89(10): 981 - 982. [Full Text] [PDF]

				J. S. March Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infection (PANDAS): Implications for Clinical Practice Arch Pediatr Adolesc Med, September 1, 2004; 158(9): 927 - 929. [Full Text] [PDF]

				Reviews of Note Journal Watch Psychiatry, August 4, 2004; 2004(804): 6 - 6. [Full Text]

				PANDAS: An Intriguing Hypothesis Worth Further Study Journal Watch Pediatrics and Adolescent Medicine, July 12, 2004; 2004(712): 9 - 9. [Full Text]

This Article Extract Full Text (PDF) P3Rs: Submit a response Alert me when this article is cited Alert me when P3Rs are posted Alert me if a correction is posted Citation Map Services E-mail this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My File Cabinet Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via ISI Web of Science (28) Citing Articles via Google Scholar Google Scholar Articles by Swedo, S. E. Articles by Rapoport, J. L. Search for Related Content PubMed PubMed Citation Articles by Swedo, S. E. Articles by Rapoport, J. L. Related Collections Neurology & Psychiatry Related AAP Red Book topics: Non-Group A or B Streptococcal and... Group A Streptococcal Infections

	Home | My Pediatrics | Journal Information | Current Issue | Past Issues | Subscriptions & Services | Contact Us Click here for faster international access © 2004 American Academy of Pediatrics. All rights reserved.